Back to Blog

Mantis Biotech Just Made Your Medical Data Problem Disappear?

Explore how New York's Mantis Biotech uses AI to create 'digital twins' of humans, solving medicine's data gaps. You'll learn what this means for your future healthcare.

Admin
Mar 31, 2026
2 min read
Mantis Biotech Just Made Your Medical Data Problem Disappear?
Mantis Biotech Just Made Your Medical Data Problem Disappear?

Editorial Note

Reviewed and analysis by ScoRpii Tech Editorial Team.

Imagine a future where clinical trials don't always involve real people, or where testing new drug therapies for rare diseases is no longer a data nightmare. You're not alone in thinking this sounds like science fiction, but New York-based Mantis Biotech claims it's developing the solution right now. They're pioneering 'digital twins' of humans to tackle medicine’s persistent data availability problem.

Key Details

You know the struggle: medicine often faces a critical data availability gap, especially for edge cases like rare diseases. This lack of reliable, representative data can stall crucial research. New York’s Mantis Biotech, led by Founder and CEO Georgia Witchel, is directly addressing this by developing 'digital twins' of humans, aiming to revolutionize medical testing.

Mantis’ platform uses an advanced LLM-based system to route, validate, and synthesize various data streams. This information then runs through a physics engine, creating high-fidelity renders – essentially, a virtual you built from data. Witchel envisions a future where 'humans can be tested on when you’re using virtual humans,' fostering a new mindset. This innovative approach has attracted investors like Decibel VC, Y Combinator, and Liquid 2, with even the NBA showing interest in its potential beyond traditional medicine.

Why This Matters

For you, this isn't just abstract tech; it's a profound shift for healthcare. Think of how 'digital twins' could accelerate drug discovery, allowing researchers to test countless scenarios without risking actual patients. This is particularly vital for rare diseases, where finding enough human subjects for trials is a monumental challenge. It also opens the door to truly personalized medicine, where treatments are honed on your virtual counterpart before ever affecting your physical self, addressing medicine's persistent challenge of accessing rich, representative data.

The Bottom Line

The work being done by Mantis Biotech isn't just futuristic; it's actively shaping how your healthcare might look in the very near future. Keep your eye on 'digital twins' as they move from concept to medical reality. You should understand that this innovation could lead to faster, safer, and more personalized medical solutions for you and your loved ones, making once-impossible treatments a tangible reality. It's a powerful step towards a more data-driven, precise era of medicine.

Originally reported by

TechCrunch

Share this article

What did you think?